Early intracardiac thrombosis in preterm infants and thrombolysis with recombinant tissue type plasminogen activator
- aDepartment of Paediatrics, Division of Neonatology, Modena University, Italy, bDepartment of Embryology, Histology and Genetics
- Prof Ferrari, Department of Paediatrics, Division of Neonatology, University Hospital, Via del Pozzo, 41100 Modena, Italy
- Accepted 11 September 2000
OBJECTIVES To determine the incidence of catheter related thrombosis and to test the efficacy of recombinant tissue type plasminogen activator (rt-PA) in preterm infants.
STUDY DESIGN From January 1995 to December 1998, echocardiography was performed in the first few days of life in 76 very low birthweight (⩽ 1500 g) infants out of a total of 147 having an umbilical catheter placed. When intracardiac thrombosis was diagnosed, rt-PA infusion was performed.
RESULTS Four infants (5%) developed an intracardiac thrombosis during the first few days of life. In three of them, rt-PA at a dose of 0.4–0.5 mg/kg in a 20–30 minute bolus led to dissolution of the clot. One patient received a three hour infusion after the bolus, at a dose of 0.1 mg/kg/h, with resolution of the thrombus. No systemic effects were observed after rt-PA infusion.
CONCLUSIONS Early thrombosis may occur as a complication of umbilical catheterisation in preterm infants; early echocardiographic detection of this disorder allows complete, safe, and rapid lysis with rt-PA.
- recombinant tissue type plasminogen activator
- very low birthweight infants